News | June 03, 2022
CMP Pharma announces calcium channel blocker ‘Norliqva’ availability
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
The product will be launched by NATCO's commercial partner Viatris.
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Subscribe To Our Newsletter & Stay Updated
